Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

GSK and Actelion drop insomnia treatment

January 30, 2011 Research and Development Actelion, GSK, insomnia

Actelion and GlaxoSmithKline are to abandon development of phase III insomnia drug almorexant because of problems with side-effects.Almorexant a dual …
News

EMA road map to prioritise pharmacovigilance

January 28, 2011 Research and Development, Sales and Marketing EMA, European Medicines Agency, pharmacovigilance

The European Medicines Agency is to prioritise issues such as pharmacovigilance over the next five years, while also looking closely …
News

Bertil Lindmark joins Almirall as R&D head

January 27, 2011 Research and Development Almirall, Bertil Lindmark, appointment, research and development

Almirall has appointed Bertil Lindmark as executive director of R&D following the retirement of Dr Per-Olof Andersson. Bertil joins the …
Appointment

Lilly Oncology chief resigns

January 27, 2011 Research and Development, Sales and Marketing Eli Lilly, John Johnson, Lilly Oncology, appointment, lilly, research and development, sales and marketing

Lilly has an unexpected search on its hands for someone to lead its oncology business after John Johnson unexpectedly announced …
News

The Evolving Role of European Regulatory Agencies

January 26, 2011 Research and Development Consultancy, regulatory affairs, regulatory agencies

The regulatory landscape can change in a very short period of time. Matthew Walker, Senior Regulatory Affairs Executive at TRAC …
Feature
Thought Leadership

Pharma-biotech partnerships: creative approaches to doing the deal

January 26, 2011 Research and Development Susan Aldridge, biotech, biotech partnerships, pharma partnering

Research and development partnerships between big pharma and the biotech sector are now a vital component in bringing new medicines …
Feature

Sanofi buys into cancer antibody research

January 26, 2011 Research and Development Cancer, Oxford Biotherapeutics, Sanofi, Sanofi-Aventis, antibody drug conjugate, cancer research

Sanofi-Aventis has bought a global licence to develop and commercialise one of Oxford BioTherapeutics’ (OBT) oncology programmes. For an undisclosed …
News

Dr Marie-Paule Richard joins AiCuris as CMO

January 26, 2011 Research and Development AiCuris, Dr Marie-Paule Richard, appointment, research and development

German clinical research company AiCuris has appointed Dr Marie-Paule Richard as chief medical officer. She has over 24 years of …
Appointment

Eisai sepsis drug fails in phase III

January 26, 2011 Research and Development, Sales and Marketing Eisai, eritoran, perampanel, sepsis

A new treatment for severe sepsis could be abandoned entirely after phase III results fell short. Eisai’s eritoran did not …
News
Amgen HQ

Amgen signs $1 billion cancer biotech deal

January 25, 2011 Research and Development Amgen, BioVex, OncoVEXGM-CSF, cancer vaccine

Amgen is set to pay $1 billion for US biotech firm BioVex, in the process gaining access to its novel …
News
GlaxoSmitKline's headquarters

GSK skin cancer drugs moves into phase III

January 25, 2011 Research and Development BRAF V600 mutation, Cancer, Duchenne Muscular Dystrophy, GSK, GSK1120212, GSK2118436, GSK968, GlaxoSmithKline, melanoma, skin cancer

GlaxoSmithKline has begun late-stage trials of two new drugs for advanced or metastatic melanoma patients. GSK2118436 and GSK1120212 are being …
News

Novartis offers $470m to boost personalised cancer treatment

January 24, 2011 Research and Development, Sales and Marketing Cancer, Genoptix, Novartis, cancer diagnostics, personalised medicine

Novartis has offered $470 million for a California-based laboratory whose diagnostic services it hopes will enhance personalised treatment. Genoptix specialises …
News

Contract research news in brief

January 24, 2011 Research and Development AMRI, Applied Clinical Intelligence, Cenix Bioscience, Clinipace Worldwide, ICON, PPD, Pacific Biomarkers, monoclonal antibody

PPD sets up a monoclonal antibody JV in Singapore, plus updates from Icon plc, Cenix Bioscience, Clinipace Worldwide, Pacific Biomarkers, …
News

Penn Pharma appoints Wyeth’s Edward Rowland

January 20, 2011 Manufacturing and Production, Research and Development Edward Rowland, Penn Pharma, appointment, manufacturing and production, research and development

Edward Rowland has joined Wales-based pharmaceutical drug developer and manufacturer Penn Pharma as head of operational analytical services. He moves …
Appointment
Roche building

Trial success for Roche’s personalised skin cancer drug

January 19, 2011 Research and Development BRAF V600, Cancer, RG7204, Roche, personalised medicine, skin cancer

A promising Roche drug has helped previously untreated patients with advanced skin cancer to live longer without their disease getting …
News
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026